EX-99.3 4 d799418dex993.htm EX-99.3 EX-99.3

Exhibit 99.3

 

LOGO

Cameco Corporation

2024 condensed consolidated interim financial statements

(unaudited)

April 29, 2024


Cameco Corporation

Consolidated statements of earnings

 

(Unaudited)    Note      Three months ended  

($Cdn thousands, except per share amounts)

          Mar 31/24     Mar 31/23  

Revenue from products and services

     12      $ 633,545     $ 686,975  

Cost of products and services sold

        403,558       443,422  

Depreciation and amortization

        43,167       76,373  
     

 

 

   

 

 

 

Cost of sales

        446,725       519,795  
     

 

 

   

 

 

 

Gross profit

        186,820       167,180  

Administration

        59,808       64,011  

Exploration

        7,360       6,279  

Research and development

        9,320       4,232  

Other operating income

     10        (16,780     (2,047

Loss on disposal of assets

        370       —   
     

 

 

   

 

 

 

Earnings from operations

        126,742       94,705  

Finance costs

     13        (38,145     (23,597

Gain (loss) on derivatives

     19        (41,278     2,270  

Finance income

        6,323       27,540  

Share of earnings (loss) from equity-accounted investees

     7        (46,346     56,536  

Other income (expense)

     14        16,603       (2,586
     

 

 

   

 

 

 

Earnings before income taxes

        23,899       154,868  

Income tax expense

     15        30,960       35,904  
     

 

 

   

 

 

 

Net earnings (loss)

      $ (7,061   $ 118,964  
     

 

 

   

 

 

 

Net earnings (loss) attributable to:

       

Equity holders

        (7,056     118,969  

Non-controlling interest

        (5     (5
     

 

 

   

 

 

 

Net earnings (loss)

      $ (7,061   $ 118,964  
     

 

 

   

 

 

 

Earnings (loss) per common share attributable to equity holders:

       

Basic

     16      $ (0.02   $ 0.27  
     

 

 

   

 

 

 

Diluted

     16      $ (0.02   $ 0.27  
     

 

 

   

 

 

 

See accompanying notes to condensed consolidated interim financial statements.

 

2


Cameco Corporation

Consolidated statements of comprehensive earnings

 

(Unaudited)    Note      Three months ended  

($Cdn thousands)

          Mar 31/24     Mar 31/23  

Net earnings (loss)

      $ (7,061   $ 118,964  

Other comprehensive income (loss), net of taxes:

       

Items that will not be reclassified to net earnings:

       

Remeasurements of defined benefit liability - equity-accounted investee1

        (31     —   

Items that are or may be reclassified to net earnings:

       

Exchange differences on translation of foreign operations

        38,199       (2,631

Gains on derivatives designated as cash flow hedges -equity-accounted investee2

        3,949       —   

Exchange differences on translation of foreign operations - equity-accounted investee

        (12,152     —   
     

 

 

   

 

 

 

Other comprehensive income (loss), net of taxes

        29,965       (2,631
     

 

 

   

 

 

 

Total comprehensive income

      $ 22,904     $ 116,333  
     

 

 

   

 

 

 

Other comprehensive income (loss) attributable to

       

Equity holders

      $ 29,965     $ (2,631

Non-controlling interest

        —        —   
     

 

 

   

 

 

 

Other comprehensive income (loss)

      $ 29,965     $ (2,631
     

 

 

   

 

 

 

Total comprehensive income attributable to

       

Equity holders

      $ 22,909     $ 116,338  

Non-controlling interest

        (5     (5
     

 

 

   

 

 

 

Total comprehensive income

      $ 22,904     $ 116,333  
     

 

 

   

 

 

 

 

1 

Net of tax (Q1 2024 - $10)

2 

Net of tax (Q1 2024 - $(2,213))

See accompanying notes to condensed consolidated interim financial statements.

 

3


Cameco Corporation

Consolidated statements of financial position

 

(Unaudited)    Note      As at  

($Cdn thousands)

          Mar 31/24      Dec 31/23  

Assets

        

Current assets

        

Cash and cash equivalents

      $ 323,217      $ 566,809  

Accounts receivable

        206,768        422,333  

Current tax assets

        1,049        974  

Inventories

     5        761,102        692,261  

Supplies and prepaid expenses

        154,038        149,352  

Current portion of long-term receivables, investments and other

     6        24,421        10,161  
     

 

 

    

 

 

 

Total current assets

        1,470,595        1,841,890  
     

 

 

    

 

 

 

Property, plant and equipment

        3,320,426        3,368,772  

Intangible assets

        42,657        43,577  

Long-term receivables, investments and other

     6        600,303        613,773  

Investment in equity-accounted investees

     7        3,194,120        3,173,185  

Deferred tax assets

        874,933        892,860  
     

 

 

    

 

 

 

Total non-current assets

        8,032,439        8,092,167  
     

 

 

    

 

 

 

Total assets

      $ 9,503,034      $ 9,934,057  
     

 

 

    

 

 

 

Liabilities and shareholders’ equity

        

Current liabilities

        

Accounts payable and accrued liabilities

        376,713        577,550  

Current tax liabilities

        25,200        24,076  

Current portion of long-term debt

     8        499,910        499,821  

Current portion of other liabilities

     9        72,055        48,544  

Current portion of provisions

     10        59,059        39,113  
     

 

 

    

 

 

 

Total current liabilities

        1,032,937        1,189,104  
     

 

 

    

 

 

 

Long-term debt

     8        1,032,172        1,284,353  

Other liabilities

     9        343,258        343,420  

Provisions

     10        982,768        1,022,871  
     

 

 

    

 

 

 

Total non-current liabilities

        2,358,198        2,650,644  
     

 

 

    

 

 

 

Shareholders’ equity

        

Share capital

     11        2,914,770        2,914,165  

Contributed surplus

        209,729        215,679  

Retained earnings

        2,972,656        2,979,743  

Other components of equity

        14,714        (15,282
     

 

 

    

 

 

 

Total shareholders’ equity attributable to equity holders

        6,111,869        6,094,305  

Non-controlling interest

        30        4  
     

 

 

    

 

 

 

Total shareholders’ equity

        6,111,899        6,094,309  
     

 

 

    

 

 

 

Total liabilities and shareholders’ equity

      $ 9,503,034      $ 9,934,057  
     

 

 

    

 

 

 

Commitments and contingencies [notes 10, 15]

See accompanying notes to condensed consolidated interim financial statements.

 

4


Cameco Corporation

Consolidated statements of changes in equity

 

     Attributable to equity holders              

(Unaudited)

($Cdn thousands)

   Share
capital
     Contributed
surplus
    Retained
earnings
    Foreign
currency
translation
    Cash
flow
hedges
     Equity
investments
at FVOCI
    Total     Non-
controlling
interest
    Total
equity
 

Balance at January 1, 2024

   $ 2,914,165      $ 215,679     $ 2,979,743     $ (18,040   $ 3,506      $ (748   $ 6,094,305     $ 4     $ 6,094,309  

Net loss

     —         —        (7,056     —        —         —        (7,056     (5     (7,061

Other comprehensive income (loss)

     —         —        (31     26,047       3,949        —        29,965       —        29,965  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Total comprehensive income (loss) for the period

     —         —        (7,087     26,047       3,949        —        22,909       (5     22,904  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Share-based compensation

     —         1,288       —        —        —         —        1,288       —        1,288  

Stock options exercised

     605        (114     —        —        —         —        491       —        491  

Restricted share units released

     —         (7,124     —        —        —         —        (7,124     —        (7,124

Transactions with owners - contributed equity

     —         —        —        —        —         —        —        31       31  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Balance at March 31, 2024

   $ 2,914,770      $ 209,729     $ 2,972,656     $ 8,007     $ 7,455      $ (748   $ 6,111,869     $ 30     $ 6,111,899  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Balance at January 1, 2023

   $ 2,880,336      $ 224,687     $ 2,696,379     $ 35,400     $ —       $ (748   $ 5,836,054     $ 11     $ 5,836,065  

Net earnings (loss)

     —         —        118,969       —        —         —        118,969       (5     118,964  

Other comprehensive loss

     —         —        —        (2,631     —         —        (2,631     —        (2,631
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Total comprehensive income (loss) for the period

     —         —        118,969       (2,631     —         —        116,338       (5     116,333  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Share-based compensation

     —         849       —        —        —         —        849       —        849  

Stock options exercised

     11,800        (2,188     —        —        —         —        9,612       —        9,612  

Restricted share units released

     —         (6,408     —        —        —         —        (6,408     —        (6,408

Dividends

     —         —        3       —        —         —        3       —        3  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Balance at March 31, 2023

   $ 2,892,136      $ 216,940     $ 2,815,351     $ 32,769     $ —       $ (748   $ 5,956,448     $ 6     $ 5,956,454  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

See accompanying notes to condensed consolidated interim financial statements.

 

5


Cameco Corporation

Consolidated statements of cash flows

 

(Unaudited)    Note      Three months ended  

($Cdn thousands)

          Mar 31/24     Mar 31/23  

Operating activities

       

Net earnings (loss)

      $ (7,061   $ 118,964  

Adjustments for:

       

Depreciation and amortization

        43,167       76,373  

Deferred charges

        (24,282     (14,942

Unrealized loss (gain) on derivatives

        34,644       (6,282

Share-based compensation

     18        1,288       849  

Loss on disposal of assets

        370       —   

Finance costs

     13        38,145       23,597  

Finance income

        (6,323     (27,540

Share of loss (earnings) in equity-accounted investees

     7        46,346       (56,536

Other operating income

     10        (16,780     (2,047

Other expense (income)

        (16,603     2,586  

Income tax expense

     15        30,960       35,904  

Interest received

        6,323       27,444  

Income taxes paid

        (11,883     (7,460

Other operating items

     17        (55,154     44,246  
     

 

 

   

 

 

 

Net cash provided by operations

        63,157       215,156  
     

 

 

   

 

 

 

Investing activities

       

Additions to property, plant and equipment

        (40,019     (26,909

Decrease in short-term investments

        —        307,952  
     

 

 

   

 

 

 

Net cash provided by (used in) investing

        (40,019     281,043  
     

 

 

   

 

 

 

Financing activities

       

Decrease in debt

        (268,300     —   

Interest paid

        (2,523     (790

Lease principal payments

        (412     (585

Proceeds from issuance of shares, stock option plan

        491       9,612  

Dividends returned

        —        4  
     

 

 

   

 

 

 

Net cash provided by (used in) financing

        (270,744     8,241  
     

 

 

   

 

 

 

Increase (decrease) in cash and cash equivalents, during the period

        (247,606     504,440  

Exchange rate changes on foreign currency cash balances

        4,014       (1,231

Cash and cash equivalents, beginning of period

        566,809       1,143,674  
     

 

 

   

 

 

 

Cash and cash equivalents, end of period

      $ 323,217     $ 1,646,883  
     

 

 

   

 

 

 

Cash and cash equivalents is comprised of:

       

Cash

        234,391       722,823  

Cash equivalents

        88,826       924,060  
     

 

 

   

 

 

 

Cash and cash equivalents

      $ 323,217     $ 1,646,883  
     

 

 

   

 

 

 

See accompanying notes to condensed consolidated interim financial statements.

 

6


Cameco Corporation

Notes to condensed consolidated interim financial statements

(Unaudited)

(Cdn$ thousands, except per share amounts and as noted)

1. Cameco Corporation

Cameco Corporation is incorporated under the Canada Business Corporations Act. The address of its registered office is 2121 11th Street West, Saskatoon, Saskatchewan, S7M 1J3. The condensed consolidated interim financial statements as at and for the period ended March 31, 2024 comprise Cameco Corporation and its subsidiaries (collectively, the Company or Cameco) and the Company’s interests in associates and joint arrangements.

Cameco is one of the world’s largest providers of the uranium needed to generate clean, reliable baseload electricity around the globe. The Company has operations in northern Saskatchewan and the United States, as well as a 40% interest in Joint Venture Inkai LLP (JV Inkai), a joint arrangement with Joint Stock Company National Atomic Company Kazatomprom (Kazatomprom), located in Kazakhstan. Cameco also has a 49% interest in Westinghouse Electric Company (Westinghouse), a joint venture with Brookfield Renewable Partners and its institutional partners (collectively, Brookfield). Westinghouse is one of the world’s largest nuclear services businesses with corporate headquarters in Pennsylvania and operations around the world. Both JV Inkai and Westinghouse are accounted for on an equity basis (see note 7).

Cameco has two operating mines, Cigar Lake and McArthur River. Operations at McArthur River/Key Lake, which had been suspended in 2018, resumed in November of 2022. The Rabbit Lake operation was placed in care and maintenance in 2016. Cameco’s operations in the United States, Crow Butte and Smith Ranch-Highland, are also not currently producing as the decision was made in 2016 to curtail production and defer all wellfield development. See note 20 for the financial statement impact.

The Company is also a leading provider of nuclear fuel processing services, supplying much of the world’s reactor fleet with the fuel to generate one of the cleanest sources of electricity available today. It operates the world’s largest commercial refinery in Blind River, Ontario, controls a significant portion of the world UF6 primary conversion capacity in Port Hope, Ontario and is a leading manufacturer of fuel assemblies and reactor components for CANDU reactors at facilities in Port Hope and Cobourg, Ontario.

2. Material accounting policies

A. Statement of compliance

These condensed consolidated interim financial statements have been prepared in accordance with IAS 34 Interim Financial Reporting. The condensed consolidated interim financial statements do not include all of the information required for full annual financial statements and should be read in conjunction with Cameco’s annual consolidated financial statements as at and for the year ended December 31, 2023.

These condensed consolidated interim financial statements were authorized for issuance by the Company’s board of directors on April 29, 2024.

B. Basis of presentation

These condensed consolidated interim financial statements are presented in Canadian dollars, which is the Company’s functional currency. All financial information is presented in Canadian dollars, unless otherwise noted. Amounts presented in tabular format have been rounded to the nearest thousand except per share amounts and where otherwise noted.

 

7


The condensed consolidated interim financial statements have been prepared on the historical cost basis except for the following material items which are measured on an alternative basis at each reporting date:

 

Derivative financial instruments    Fair value through profit or loss (FVTPL)
Equity securities    Fair value through other comprehensive income (FVOCI)
Liabilities for cash-settled share-based payment arrangements    Fair value through profit or loss (FVTPL)
Net defined benefit liability    Fair value of plan assets less the present value of the defined benefit obligation

The preparation of the condensed consolidated interim financial statements in conformity with International Financial Reporting Standards (IFRS) requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, revenue and expenses. Actual results may vary from these estimates.

In preparing these condensed consolidated interim financial statements, the significant judgments made by management in applying the Company’s accounting policies and key sources of estimation uncertainty were the same as those that applied to the consolidated financial statements as at and for the year ended December 31, 2023.

Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected. The areas involving a higher degree of judgment or complexity, or areas where assumptions and estimates are significant to the consolidated financial statements are disclosed in note 5 of the December 31, 2023, consolidated financial statements.

3. Accounting standards

A. Changes in accounting policy

A number of amendments to existing standards became effective January 1, 2024, but they did not have an effect on the Company’s financial statements.

B. New standards and interpretations not yet adopted

There is one new standard that is not yet effective for the period ended March 31, 2024, and has not been applied in preparing these condensed consolidated interim financial statements. Cameco does not intend to early adopt this standard and does not expect it to have a material impact on its financial statements.

i. Financial statement presentation

In April 2024, the International Accounting Standards Board (IASB) issued IFRS 18, Presentation and Disclosure of Financial Statements (IFRS 18). IFRS 18 is effective for periods beginning on or after January 1, 2027, with early adoption permitted. IFRS 18 is expected to improve the quality of financial reporting by requiring defined subtotals in the statement of profit or loss, requiring disclosure about management-defined performance measures, and adding new principles for aggregation and disaggregation of information. Cameco has not yet determined the impact of this standard on its disclosures.

 

8


4. Acquisition of Westinghouse Electric Company (Westinghouse)

On November 7, 2023, Cameco acquired a 49% interest in Westinghouse, one of the world’s largest nuclear services businesses, in partnership with Brookfield Asset Management alongside its publicly listed affiliate Brookfield Renewable Partners (Brookfield) and its institutional partners. Brookfield, with its institutional partners, owns the other 51%. The acquisition represents an investment in additional nuclear fuel cycle assets that the Company expects will augment the core of its business.

To finance its 49% share of the purchase price, $2,140,305,000 (US), Cameco used a combination of cash, debt and equity. The Company used $1,540,305,000 (US) of cash and $600,000,000 (US) in term loans (see note 8). In 2022, Cameco had issued 34,057,250 common shares pursuant to a public offering to help fund the acquisition. At March 31, 2024, $50,000,000 (US) remained in escrow.

Cameco’s share of the acquisition date fair value of the underlying assets and liabilities was as follows:

 

Net assets acquired (USD)

  

Cash and cash equivalents

   $ 255,924  

Other current assets

     955,140  

Property, plant and equipment

     795,613  

Intangible assets

     2,839,550  

Goodwill

     556,028  

Non-current assets

     346,928  

Current liabilities

     (1,163,456

Non-current liabilities

     (2,445,422
  

 

 

 

Total

   $ 2,140,305  
  

 

 

 

Cash paid

     1,540,305  

Term loans

     600,000  
  

 

 

 

Total

   $ 2,140,305  
  

 

 

 

Fair values were determined using a number of different valuation methodologies depending on the characteristics of the assets being valued. Methods included discounted cash flows, relief from royalty and multi-period excess earnings, quoted market prices and the direct cost method.

Intangible assets include customer relationships and contracts, developed technology, the Westinghouse trade name and product development costs. Goodwill reflects the value assigned to the expected future earnings capabilities of the organization. This is the earnings potential that we anticipate will be realized through new business arrangements.

The valuation of the assets and liabilities assumed has not been finalized as of the date of these financial statements. The accounting for the acquisition will be revised when the valuation is complete. Since December 31, 2023, when the acquisition was first reported, amounts have been reclassified between the net assets acquired to reflect changes in the valuation to date. Following the completion of the valuation, if new information obtained within one year of the acquisition date about facts and circumstances that existed at the date of acquisition, identifies adjustments to the above amounts, or any additional provisions that existed at the date of acquisition, further revisions will be made.

 

9


5. Inventories

 

     Mar 31/24      Dec 31/23  

Uranium

     

Concentrate

   $ 550,414      $ 511,654  

Broken ore

     57,112        71,463  
  

 

 

    

 

 

 
     607,526        583,117  

Fuel services

     153,136        108,711  

Other

     440        433  
  

 

 

    

 

 

 

Total

   $ 761,102      $ 692,261  
  

 

 

    

 

 

 

Cameco expensed $404,298,000 of inventory as cost of sales during the first quarter of 2024 (2023 - $465,069,000).

6. Long-term receivables, investments and other

 

     Mar 31/24      Dec 31/23  

Deferred charges

   $ 21,989      $ —   

Derivatives [note 19]

     7,277        28,467  

Investment tax credits

     95,940        95,940  

Amounts receivable related to tax dispute [note 15](a)

     209,125        209,125  

Product loan(b)

     288,294        288,294  

Other

     2,099        2,108  
  

 

 

    

 

 

 
     624,724        623,934  

Less current portion

     (24,421      (10,161
  

 

 

    

 

 

 

Net

   $ 600,303      $ 613,773  
  

 

 

    

 

 

 

 

(a)

Cameco was required to remit or otherwise secure 50% of the cash taxes and transfer pricing penalties, plus related interest and instalment penalties assessed, in relation to its dispute with Canada Revenue Agency (CRA). In light of our view of the likely outcome of the case, Cameco expects to recover the amounts remitted to CRA, including cash taxes, interest and penalties paid.

(b)

Cameco loaned 5,400,000 pounds of uranium concentrate to its joint venture partner, Orano Canada Inc., (Orano). Orano is obligated to repay the Company in kind with uranium concentrate no later than December 31, 2028. As at March 31, 2024, 3,000,000 pounds have been returned as repayment on this loan (December 31, 2023 - 3,000,000 pounds).

Cameco also loaned Orano 1,148,200 kgU of conversion supply and an additional 1,200,000 pounds of uranium concentrate during 2022 and 2023. Repayment to Cameco is to be made in kind with U3O8 quantities drawn being repaid by December 31, 2027 and quantities of UF6 conversion supply drawn by December 31, 2035.

As at March 31, 2024, 3,600,000 pounds of U3O8 (December 31, 2023 - 3,600,000 pounds) and 1,148,200 kgU of UF6 conversion supply (December 31, 2023 - 1,148,200 kgU) were drawn on the loans and are recorded at Cameco’s weighted average cost of inventory.

 

10


7. Equity-accounted investees

 

     Mar 31/24      Dec 31/23  

Interest in Westinghouse

   $ 2,831,752      $ 2,899,379  

Interest in JV Inkai

     362,368        273,806  

Interest in Global Laser Enrichment (GLE)

     —         —   
  

 

 

    

 

 

 
   $ 3,194,120      $ 3,173,185  
  

 

 

    

 

 

 

A. Joint ventures

i. Westinghouse

Westinghouse is a nuclear reactor technology original equipment manufacturer and a global provider of products and services to commercial utilities and government agencies. Effective November 7, 2023, Cameco holds a 49% interest and Brookfield holds 51%. Cameco has joint control with Brookfield over the strategic operating, investing and financing activities of Westinghouse. The Company determined that the joint arrangement should be classified as a joint venture after concluding that neither the legal form of the separate entity, the terms of the contractual arrangement, or other facts and circumstances would give the Company rights to the assets and obligations for the liabilities relating to the arrangement. As a result, Cameco accounts for Westinghouse on an equity basis.

Westinghouse provides outage and maintenance services, engineering support, instrumentation and controls equipment, plant modification, and components and parts to nuclear reactors. Westinghouse has three fabrication facilities that design and manufacture nuclear fuel supplies for light water reactors. In addition, Westinghouse designs, develops and procures equipment for the build of new nuclear reactor plants.

The following table summarizes the total comprehensive loss of Westinghouse (100%):

 

     Mar 31/24      Mar 31/23  

Revenue from products and services

   $ 1,337,804      $ —   

Cost of products and services sold

     (601,723      —   

Depreciation and amortization

     (172,849      —   

Marketing, administrative and general expenses

     (684,061      —   

Finance income

     3,939        —   

Finance costs

     (130,852      —   

Other expense

     (80,582      —   

Income tax recovery

     76,332        —   
  

 

 

    

 

 

 

Net loss

     (251,992      —   

Other comprehensive loss

     (16,804      —   
  

 

 

    

 

 

 

Total comprehensive income

   $ (268,796    $ —   
  

 

 

    

 

 

 

Cameco did not acquire its interest in Westinghouse until November 7, 2023.

 

11


The following table summarizes the financial information of Westinghouse (100%) and reconciles it to the carrying amount of Cameco’s interest:

 

     Mar 31/24      Dec 31/23  

Cash and cash equivalents

   $ 275,712      $ 265,146  

Other current assets

     2,388,847        2,364,602  

Intangible assets

     7,679,998        7,655,386  

Goodwill

     1,537,830        1,534,947  

Non-current assets

     2,854,602        3,102,566  

Current liabilities

     (2,301,620      (2,464,058

Non-current liabilities

     (6,803,625      (6,684,673
  

 

 

    

 

 

 

Net assets

     5,631,744        5,773,916  

Net assets attributable to non-controlling interest

     (23,583      (24,036
  

 

 

    

 

 

 

Net assets attributable to shareholders

     5,608,161        5,749,880  

Cameco’s share of net assets attributable to shareholders (49%)

     2,747,999        2,817,441  

Acquisition costs(a)

     83,896        83,916  

Impact of foreign exchange

     (143      (1,978
  

 

 

    

 

 

 

Carrying amount of interest in Westinghouse

   $ 2,831,752      $ 2,899,379  
  

 

 

    

 

 

 

 

(a)

Cameco incurred $84 million of acquisition costs that were included in the cost of the investment.

ii. Global Laser Enrichment LLC (GLE)

GLE is the exclusive licensee of the proprietary Separation of Isotopes by Laser Excitation (SILEX) laser enrichment technology, a third-generation uranium enrichment technology. Cameco owns a 49% interest in GLE with an option to attain a majority interest of up to 75% ownership. Cameco has joint control with SILEX over the strategic operating, investing and financing activities and as a result, accounts for GLE on an equity basis. In 2014, an impairment charge was recognized for its full carrying value of $183,615,000. Following the impairment, under the equity method of accounting, Cameco discontinued recognizing its share of losses in GLE. Cameco’s contributions to GLE are recorded in earnings as research and development.

B. Associate

i. JV Inkai

JV Inkai is the operator of the Inkai uranium deposit located in Kazakhstan. Cameco holds a 40% interest in JV Inkai and Kazatomprom holds a 60% interest. Cameco does not have control over the joint venture so it accounts for the investment on an equity basis.

JV Inkai is a uranium mining and milling operation that utilizes in-situ recovery (ISR) technology to extract uranium. The participants in JV Inkai purchase uranium from Inkai and, in turn, derive revenue directly from the sale of such product to third-party customers.

 

12


The following tables summarize the total comprehensive earnings of JV Inkai (100%):

 

     Mar 31/24      Mar 31/23  

Revenue from products and services

   $ 313,864      $ 74,303  

Cost of products and services sold

     (38,424      (13,481

Depreciation and amortization

     (20,400      (4,521

Finance income

     562        130  

Finance costs

     (272      (259

Other expense

     (15,312      (9,730

Income tax expense

     (49,457      (9,843
  

 

 

    

 

 

 

Net earnings from continuing operations

     190,561        36,599  

Other comprehensive income

     —         —   
  

 

 

    

 

 

 

Total comprehensive income

   $ 190,561      $ 36,599  
  

 

 

    

 

 

 

The following table summarizes the financial information of JV Inkai (100%) and reconciles it to the carrying amount of Cameco’s interest:

 

     Mar 31/24      Dec 31/23  

Cash and cash equivalents

   $ 190,799      $ 24,074  

Other current assets

     606,087        551,917  

Non-current assets

     363,972        332,655  

Current liabilities

     (453,678      (40,985

Non-current liabilities

     (32,344      (30,211
  

 

 

    

 

 

 

Net assets

     674,836        837,450  

Cameco’s share of net assets (40%)

     269,934        334,980  

Consolidating adjustments(a)

     (72,450      (74,223

Fair value increment(b)

     80,319        81,090  

Dividends declared but not received

     195,207        5,952  

Dividends in excess of ownership percentage(c)

     (107,179      (74,843

Impact of foreign exchange

     (3,463      850  
  

 

 

    

 

 

 

Carrying amount of interest in JV Inkai

   $ 362,368      $ 273,806  
  

 

 

    

 

 

 

 

(a)

Cameco records certain consolidating adjustments to eliminate unrealized profit, recognize deferred profit and amortize historical differences in accounting policies. The historical differences are amortized to earnings over units of production.

(b)

Upon restructuring, Cameco assigned fair values to the assets and liabilities of JV Inkai. This increment is amortized to earnings over units of production.

(c)

Cameco’s share of dividends follows its production purchase entitlements which is currently higher than its ownership interest.

 

13


8. Long-term debt

 

     Mar 31/24      Dec 31/23  

Unsecured debentures

     

Series F - 5.09% debentures due November 14, 2042

   $ 99,380      $ 99,374  

Series G - 4.19% debentures due June 24, 2024

     499,910        499,821  

Series H - 2.95% debentures due October 21, 2027

     398,670        398,582  

Term loans

     534,122        786,397  
  

 

 

    

 

 

 
     1,532,082        1,784,174  

Less current portion

     (499,910      (499,821
  

 

 

    

 

 

 

Total

   $ 1,032,172      $ 1,284,353  
  

 

 

    

 

 

 

On November 7, 2023, the Company utilized a term loan for $600,000,000 (US) with a syndicate of lenders. The proceeds of the term loan were used to finance the 49% acquisition of Westinghouse. The term loan consisted of two $300,000,000 (US) tranches. The first tranche has a floating interest rate of SOFR plus 1.80% and matures on November 7, 2025. The second tranche has a floating interest rate of SOFR plus 2.05% and matures on November 7, 2026. On February 8, 2024, Cameco repaid $200,000,000 (US) on the tranche which matures in 2026.

9. Other liabilities

 

     Mar 31/24      Dec 31/23  

Deferred sales

   $ 57,712      $ 45,372  

Derivatives [note 19]

     35,798        22,344  

Accrued pension and post-retirement benefit liability

     77,857        77,002  

Lease obligation [note 19]

     10,512        10,816  

Product loans(a)

     166,563        166,052  

Sales contracts [note 4]

     5,644        6,314  

Other

     61,227        64,064  
  

 

 

    

 

 

 
     415,313        391,964  

Less current portion

     (72,055      (48,544
  

 

 

    

 

 

 

Net

   $ 343,258      $ 343,420  
  

 

 

    

 

 

 

 

(a)

Cameco has standby product loan facilities with various counterparties. The arrangements allow us to borrow up to 1,978,000 kgU of UF6 conversion services and 6,679,000 pounds of U3O8 by September 30, 2027 with repayment in kind up to December 31, 2027. Under the facilities, standby fees of up to 1.5% are payable based on the market value of the facilities and interest is payable on the market value of any amounts drawn at rates ranging from 0.5% to 3.0%. At March 31, 2024, we have 1,777,000 kgU of UF6 conversion services (December 31, 2023 - 1,777,000 kgU) drawn on the loans with repayment due by December 31 of the following years:

 

     2024      2025      2026      2027      Total  

kgU of UF6

     —         528,000        1,249,000        —         1,777,000  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

14


We also have 2,756,000 pounds of U3O8 (December 31, 2023 - 2,756,000 pounds) drawn with repayment due no later than December 31 of the following years:

 

     2024      2025      2026      2027      Total  

lbs of U3O8

     —         630,000        2,126,000        —         2,756,000  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

The loans are recorded at Cameco’s weighted average cost of inventory.

10. Provisions

 

     Reclamation      Waste disposal      Total  

Beginning of year

   $ 1,051,167      $ 10,817      $ 1,061,984  

Changes in estimates and discount rates

        

Capitalized in property, plant, and equipment

     (11,309      —         (11,309

Recognized in earnings

     (16,780      —         (16,780

Provisions used during the period

     (7,258      (550      (7,808

Unwinding of discount

     8,687        86        8,773  

Impact of foreign exchange

     6,967        —         6,967  
  

 

 

    

 

 

    

 

 

 

End of period

   $ 1,031,474      $ 10,353      $ 1,041,827  
  

 

 

    

 

 

    

 

 

 

Current

     55,007        4,052        59,059  

Non-current

     976,467        6,301        982,768  
  

 

 

    

 

 

    

 

 

 
   $ 1,031,474      $ 10,353      $ 1,041,827  
  

 

 

    

 

 

    

 

 

 

11. Share capital

At March 31, 2024, there were 434,205,752 common shares outstanding. Options in respect of 1,366,289 shares are outstanding under the stock option plan and are exercisable up to 2027. For the three months ended March 31, 2024, there were 30,000 options exercised that resulted in the issuance of shares (2023 - 513,717).

12. Revenue

Cameco’s uranium and fuel services sales contracts with customers contain both fixed and market-related pricing. Fixed-price contracts are typically based on a term-price indicator at the time the contract is accepted and escalated over the term of the contract. Market-related contracts are based on either the spot price or long-term price, and the price is quoted at the time of delivery rather than at the time the contract is accepted. These contracts often include a floor and/or ceiling prices, which are usually escalated over the term of the contract. Escalation is generally based on a consumer price index. The Company’s contracts contain either one of these pricing mechanisms or a combination of the two. There is no variable consideration in the contracts and therefore no revenue is considered constrained at the time of delivery. Cameco expenses the incremental costs of obtaining a contract as incurred as the amortization period is less than a year.

 

15


The following tables summarize Cameco’s sales disaggregated by geographical region and contract type and includes a reconciliation to Cameco’s reportable segments (note 20):

For the three months ended March 31, 2024

 

     Uranium      Fuel services      Total  

Customer geographical region

        

Americas

   $ 421,917      $ 61,253      $ 483,170  

Europe

     67,131        10,761        77,892  

Asia

     72,062        421        72,483  
  

 

 

    

 

 

    

 

 

 
   $ 561,110      $ 72,435      $ 633,545  
  

 

 

    

 

 

    

 

 

 

Contract type

        

Fixed-price

   $ 157,927      $ 63,614      $ 221,541  

Market-related

     403,183        8,821        412,004  
  

 

 

    

 

 

    

 

 

 
   $ 561,110      $ 72,435      $ 633,545  
  

 

 

    

 

 

    

 

 

 

For the three months ended March 31, 2023

 

     Uranium      Fuel services      Total  

Customer geographical region

        

Americas

   $ 234,273      $ 66,170      $ 300,443  

Europe

     178,142        19,191        197,333  

Asia

     182,161        7,038        189,199  
  

 

 

    

 

 

    

 

 

 
   $ 594,576      $ 92,399      $ 686,975  
  

 

 

    

 

 

    

 

 

 

Contract type

        

Fixed-price

   $ 201,953      $ 92,399      $ 294,352  

Market-related

     392,623        —         392,623  
  

 

 

    

 

 

    

 

 

 
   $ 594,576      $ 92,399      $ 686,975  
  

 

 

    

 

 

    

 

 

 

 

16


13. Finance costs

 

     Three months ended  
     Mar 31/24      Mar 31/23  

Interest on long-term debt

   $ 24,372      $ 10,377  

Unwinding of discount on provisions

     8,773        9,339  

Other charges

     5,000        3,881  
  

 

 

    

 

 

 

Total

   $ 38,145      $ 23,597  
  

 

 

    

 

 

 

14. Other income (expense)

 

     Three months ended  
     Mar 31/24      Mar 31/23  

Foreign exchange gains (losses)

     16,607        (2,586

Other

     (4      —   
  

 

 

    

 

 

 

Total

   $ 16,603      $ (2,586
  

 

 

    

 

 

 

15. Income taxes

 

     Three months ended  
     Mar 31/24      Mar 31/23  

Earnings (loss) before income taxes

     

Canada

   $ 140,574      $ 149,619  

Foreign

     (116,675      5,249  
  

 

 

    

 

 

 
   $ 23,899      $ 154,868  
  

 

 

    

 

 

 

Current income taxes

     

Canada

   $ 11,354      $ 11,885  

Foreign

     1,445        2,423  
  

 

 

    

 

 

 
   $ 12,799      $ 14,308  

Deferred income taxes (recovery)

     

Canada

   $ 19,456      $ 20,808  

Foreign

     (1,295      788  
  

 

 

    

 

 

 
   $ 18,161      $ 21,596  
  

 

 

    

 

 

 

Income tax expense

   $ 30,960      $ 35,904  
  

 

 

    

 

 

 

Cameco has recorded $874,933,000 of deferred tax assets (December 31, 2023 - $892,860,000). The realization of these deferred tax assets is dependent upon the generation of future taxable income in certain jurisdictions during the periods in which the Company’s temporary tax differences are available. The Company considers whether it is probable that all or a portion of the deferred tax assets will not be realized. In making this assessment, management considers all available evidence, including recent financial operations, projected future taxable income and tax planning strategies. Based on projections of future taxable income over the periods in which the deferred tax assets are available, realization of these deferred tax assets is probable and consequently the deferred tax assets have been recorded.

 

17


Cameco has operations in countries where the global minimum top-up tax has been enacted or substantively enacted effective January 1, 2024, including: Switzerland, Luxembourg, Germany and the United Kingdom. The Company expects to be within the scope in Canada, where draft legislation has been released and is anticipated to come into effect in 2024. The exposure is currently only in Switzerland, as all other constituent entities have effective tax rates higher than 15% and the transitional safe harbour rules are expected to be met. As a result of this exposure, additional income tax expense of $345,000 has been recorded relating to the profits earned in Switzerland (2023 - $0).

Canada

On February 18, 2021, the Supreme Court of Canada (Supreme Court) dismissed Canada Revenue Agency’s (CRA) application for leave to appeal the June 26, 2020 decision of the Federal Court of Appeal (Court of Appeal). The dismissal means that the dispute for the 2003, 2005 and 2006 tax years is fully and finally resolved in the Company’s favour.

In September 2018, the Tax Court of Canada (Tax Court) ruled that the marketing and trading structure involving foreign subsidiaries, as well as the related transfer pricing methodology used for certain intercompany uranium sales and purchasing agreements, were in full compliance with Canadian law for the tax years in question. Management believes the principles in the decision apply to all subsequent tax years, and that the ultimate resolution of those years will not be material to Cameco’s financial position, results of operations or liquidity in the year(s) of resolution.

As CRA continues to pursue reassessments for tax years subsequent to 2006, Cameco is utilizing its appeal rights under Canadian federal and provincial tax rules.

16. Per share amounts

Per share amounts have been calculated based on the weighted average number of common shares outstanding during the period. The weighted average number of paid shares outstanding in 2024 was 434,185,471 (2023 - 432,850,340).

 

     Three months ended  
     Mar 31/24      Mar 31/23  

Basic earnings (loss) per share computation

     

Net earnings (loss) attributable to equity holders

   $ (7,056    $ 118,969  

Weighted average common shares outstanding

     434,185        432,850  
  

 

 

    

 

 

 

Basic earnings (loss) per common share

   $ (0.02    $ 0.27  
  

 

 

    

 

 

 

Diluted earnings (loss) per share computation

     

Net earnings (loss) attributable to equity holders

   $ (7,056    $ 118,969  

Weighted average common shares outstanding

     434,185        432,850  

Dilutive effect of stock options

     —         1,707  
  

 

 

    

 

 

 

Weighted average common shares outstanding, assuming dilution

     434,185        434,557  
  

 

 

    

 

 

 

Diluted earnings (loss) per common share

   $ (0.02    $ 0.27  
  

 

 

    

 

 

 

 

(a)

For the quarter ended March 31, 2023, 1,049 options were excluded from the diluted weighted average number of common shares because their inclusion would have been anti-dilutive.

 

18


17. Statements of cash flows

 

     Three months ended  
     Mar 31/24      Mar 31/23  

Changes in non-cash working capital:

     

Accounts receivable

   $ 252,901      $ 35,037  

Inventories

     (60,768      200,691  

Supplies and prepaid expenses

     (4,526      (10,913

Accounts payable and accrued liabilities

     (228,041      (168,043

Reclamation payments

     (7,808      (8,893

Other

     (6,912      (3,633
  

 

 

    

 

 

 

Other operating items

   $ (55,154    $ 44,246  
  

 

 

    

 

 

 

18. Share-based compensation plans

A. Stock option plan

The aggregate number of common shares that may be issued pursuant to the Cameco stock option plan shall not exceed 43,017,198 of which 32,226,059 shares have been issued. As of March 31, 2024, the total number of stock options held by the participants was 1,366,289 (December 31, 2023 - 1,396,289).

B. Executive performance share unit (PSU)

During the quarter, the Company granted 178,600 PSUs. The weighted average fair value per unit at the date of issue was $55.00. As of March 31, 2024, the total number of PSUs held by the participants was 635,312 (December 31, 2023 - 830,279).

C. Restricted share unit (RSU)

During the quarter, the Company granted 322,267 RSUs. The weighted average fair value per unit at the date of issue was $55.00. As of March 31, 2024, the total number of RSUs held by the participants was 746,289 (December 31, 2023 - 814,683).

D. Deferred share unit (DSU)

As of March 31, 2024, the total number of DSUs held by participating directors was 568,071 (December 31, 2023 - 564,401).

Equity-settled plans

Cameco records compensation expense under its equity-settled plans with an offsetting credit to contributed surplus, to reflect the estimated fair value of units granted to employees. During the period, the Company recognized the following expenses under these plans:

 

     Three months ended  
     Mar 31/24      Mar 31/23  

Employee share ownership plan(a)

   $ 1,080      $ 914  

Restricted share unit plan

     1,288        849  
  

 

 

    

 

 

 

Total

   $ 2,368      $ 1,763  
  

 

 

    

 

 

 

 

(a)

The total number of shares purchased in 2024 with Company contributions was 18,331 (2023 - 25,527).

 

19


Cash-settled plans

During the period, the Company recognized the following expenses (income) under these plans:

 

     Three months ended  
     Mar 31/24      Mar 31/23  

Performance share unit plan

   $ 3,522      $ 8,127  

Deferred share unit plan

     861        2,575  

Restricted share unit plan

     2,811        6,133  

Phantom stock option plan

     70        485  

Phantom restricted share unit plan

     166        140  
  

 

 

    

 

 

 
   $ 7,430      $ 17,460  
  

 

 

    

 

 

 

Expenses related to share-based compensation plans are primarily included as part of administration expense in the statement of earnings.

19. Financial instruments and related risk management

A. Accounting classifications

The following tables summarize the carrying amounts and accounting classifications of Cameco’s financial instruments at the reporting date:

 

At March 31, 2024

 
     FVTPL      Amortized
cost
     Total  

Financial assets

        

Cash and cash equivalents(a)

   $ —       $ 323,217      $ 323,217  

Accounts receivable

     —         206,768        206,768  

Derivative assets [note 6]

        

Foreign currency contracts

     7,277        —         7,277  
  

 

 

    

 

 

    

 

 

 
     7,277        529,985        537,262  
  

 

 

    

 

 

    

 

 

 

Financial liabilities

        

Accounts payable and accrued liabilities

     —         376,713        376,713  

Lease obligation [note 9]

     —         10,512        10,512  

Current portion of long-term debt

     —         499,910        499,910  

Derivative liabilities [note 9]

        

Foreign currency contracts

     28,576        —         28,576  

Interest rate contracts

     7,222        —         7,222  

Long-term debt

     —         1,032,172        1,032,172  
  

 

 

    

 

 

    

 

 

 
     35,798        1,919,307        1,955,105  
  

 

 

    

 

 

    

 

 

 

Net

     (28,521      (1,389,322      (1,417,843
  

 

 

    

 

 

    

 

 

 

 

20


At December 31, 2023

 
     FVTPL      Amortized
cost
     Total  

Financial assets

        

Cash and cash equivalents

   $ —       $ 566,809      $ 566,809  

Accounts receivable

     —         422,333        422,333  

Derivative assets [note 6]

        

Foreign currency contracts

     28,467        —         28,467  
  

 

 

    

 

 

    

 

 

 
   $ 28,467      $ 989,142      $ 1,017,609  
  

 

 

    

 

 

    

 

 

 

Financial liabilities

        

Accounts payable and accrued liabilities

   $ —       $ 577,550      $ 577,550  

Lease obligation [note 9]

     —         10,816        10,816  

Current portion of long-term debt

     —         499,821        499,821  

Derivative liabilities [note 9]

        

Foreign currency contracts

     16,525        —         16,525  

Interest rate contracts

     5,819        —         5,819  

Long-term debt

     —         1,284,353        1,284,353  
  

 

 

    

 

 

    

 

 

 
     22,344        2,372,540        2,394,884  
  

 

 

    

 

 

    

 

 

 

Net

   $ 6,123      $ (1,383,398    $ (1,377,275
  

 

 

    

 

 

    

 

 

 

 

(a)

Cameco has pledged $158,418,000 of cash as security against certain of its letter of credit facilities. This cash is being used as collateral for an interest rate reduction on the letter of credit facilities. The collateral account has a term of five years effective November 1, 2023. Cameco retains full access to this cash.

 

B.

Fair value hierarchy

The fair value of an asset or liability is generally estimated as the amount that would be received on sale of an asset, or paid to transfer a liability in an orderly transaction between market participants at the reporting date. Fair values of assets and liabilities traded in an active market are determined by reference to last quoted prices, in the principal market for the asset or liability. In the absence of an active market for an asset or liability, fair values are determined based on market quotes for assets or liabilities with similar characteristics and risk profiles, or through other valuation techniques. Fair values determined using valuation techniques require the use of inputs, which are obtained from external, readily observable market data when available. In some circumstances, inputs that are not based on observable data must be used. In these cases, the estimated fair values may be adjusted in order to account for valuation uncertainty, or to reflect the assumptions that market participants would use in pricing the asset or liability.

All fair value measurements are categorized into one of three hierarchy levels, described below, for disclosure purposes. Each level is based on the transparency of the inputs used to measure the fair values of assets and liabilities:

Level 1 – Values based on unadjusted quoted prices in active markets that are accessible at the reporting date for identical assets or liabilities.

Level 2 – Values based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability.

Level 3 – Values based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement.

 

21


When the inputs used to measure fair value fall within more than one level of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety.

The following tables summarize the carrying amounts and level 2 fair values of Cameco’s financial instruments that are measured at fair value:

 

As at March 31, 2024

 

     Carrying value      Fair Value  

Derivative assets [note 6]

     

Foreign currency contracts

   $ 7,277      $ 7,277  

Current portion of long-term debt

     (499,910      (500,000

Derivative liabilities [note 9]

     

Foreign currency contracts

     (28,576      (28,576

Interest rate contracts

     (7,222      (7,222

Long-term debt

     (1,032,172      (1,046,504
  

 

 

    

 

 

 

Net

   $ (1,560,603    $ (1,575,025
  

 

 

    

 

 

 

 

As at December 31, 2023

 

     Carrying value      Fair Value  

Derivative assets [note 6]

     

Foreign currency contracts

   $ 28,467      $ 28,467  

Current portion of long-term debt

     (499,821      (500,000

Derivative liabilities [note 9]

     

Foreign currency contracts

     (16,525      (16,525

Interest rate contracts

     (5,819      (5,819

Long-term debt

     (1,284,353      (1,303,681
  

 

 

    

 

 

 

Net

   $ (1,778,051    $ (1,797,558
  

 

 

    

 

 

 

The preceding tables exclude fair value information for financial instruments whose carrying amounts are a reasonable approximation of fair value. The carrying value of Cameco’s cash and cash equivalents, accounts receivable, and accounts payable and accrued liabilities approximates its fair value as a result of the short-term nature of the instruments.

There were no transfers between level 1 and level 2 during the period. Cameco does not have any financial instruments that are classified as level 1 or level 3 as of the reporting date.

 

C.

Financial instruments measured at fair value

Cameco measures its derivative financial instruments and long-term debt at fair value. Derivative financial instruments and current and long-term debt are classified as recurring level 2 fair value measurements.

The fair value of Cameco’s unsecured debentures is determined using quoted market yields as of the reporting date, which ranged from 3.4% to 4.9% (2023 - 3.1% to 4.9%). The fair value of the floating rate term loan is equal to its carrying value.

Foreign currency derivatives consist of foreign currency forward contracts, options and swaps. The fair value of foreign currency options is measured based on the Black Scholes option-pricing model. The fair value of foreign currency forward contracts and swaps is measured using a market approach, based on the difference between contracted foreign exchange rates and quoted forward exchange rates as of the reporting date.

 

22


Interest rate derivatives consist of interest rate swap contracts. The fair value of interest rate swaps is determined by discounting expected future cash flows from the contracts. The future cash flows are determined by measuring the difference between fixed interest payments to be received and floating interest payments to be made to the counterparty based on Canada Dealer Offer Rate forward interest rate curves.

Where applicable, the fair value of the derivatives reflects the credit risk of the instrument and includes adjustments to take into account the credit risk of the Company and counterparty. These adjustments are based on credit ratings and yield curves observed in active markets at the reporting date.

 

D.

Derivatives

The following table summarizes the fair value of derivatives and classification on the consolidated statements of financial position:

 

     Mar 31/24      Dec 31/23  

Non-hedge derivatives:

     

Foreign currency contracts

   $ (21,299    $ 11,942  

Interest rate contracts

     (7,222      (5,819
  

 

 

    

 

 

 

Net

   $ (28,521    $ 6,123  
  

 

 

    

 

 

 

Classification:

     

Current portion of long-term receivables, investments and other [note 6]

   $ 1,408      $ 9,137  

Long-term receivables, investments and other [note 6]

     5,869        19,330  

Current portion of other liabilities [note 9]

     (23,617      (14,338

Other liabilities [note 9]

     (12,181      (8,006
  

 

 

    

 

 

 

Net

   $ (28,521    $ 6,123  
  

 

 

    

 

 

 

The following table summarizes the different components of the gain (loss) on derivatives included in net earnings (loss):

 

     Three months ended  
     Mar 31/24      Mar 31/23  

Non-hedge derivatives:

     

Foreign currency contracts

   $ (39,875    $ 1,628  

Interest rate contracts

     (1,403      642  
  

 

 

    

 

 

 

Net

   $ (41,278    $ 2,270  
  

 

 

    

 

 

 

20. Segmented information

Cameco has three reportable segments: uranium, fuel services and Westinghouse. Cameco’s reportable segments are strategic business units with different products, processes and marketing strategies. The uranium segment involves the exploration for, mining, milling, purchase and sale of uranium concentrate. The fuel services segment involves the refining, conversion and fabrication of uranium concentrate and the purchase and sale of conversion services. The Westinghouse segment reflects our earnings from this equity-accounted investment (see note 7). Westinghouse is a nuclear reactor technology original equipment manufacturer and a global provider of products and services to commercial utilities and government agencies. It provides outage and maintenance services, engineering support, instrumentation and controls equipment, plant modification, and components and parts to nuclear reactors.

Cost of sales in the uranium segment includes care and maintenance costs for our operations that have had production suspensions. Cameco expensed $12,378,000 of care and maintenance costs during the first quarter of 2024 (2023 - $13,554,000).

 

23


Accounting policies used in each segment are consistent with the policies outlined in the summary of significant accounting policies.

Business segments

For the three months ended March 31, 2024

 

     Uranium     Fuel services     (i)
WEC
    (i)
Adjustments
    Other     Total  

Revenue

   $ 561,110     $ 72,435     $ 655,524     $ (655,524   $ —      $ 633,545  

Expenses

            

Cost of products and services sold

     355,860       48,404       294,844       (294,844     (706     403,558  

Depreciation and amortization

     36,715       5,319       84,696       (84,696     1,133       43,167  

Cost of sales

     392,575       53,723       379,540       (379,540     427       446,725  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit (loss)

     168,535       18,712       275,984       (275,984     (427     186,820  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Administration

     —        —        335,190       (335,190     59,808       59,808  

Exploration

     7,360       —        —        —        —        7,360  

Research and development

     —        —        —        —        9,320       9,320  

Other operating income

     (14,893     (1,887     —        —        —        (16,780

Loss on disposal of assets

     225       145       —        —        —        370  

Finance costs

     —        —        64,117       (64,117     38,145       38,145  

Gain on derivatives

     —        —        —        —        41,278       41,278  

Finance income

     —        —        (1,930     1,930       (6,323     (6,323

Share of loss (earnings) from equity-accounted investee

     (77,130     —        —        123,476       —        46,346  

Other expense (income)

     —        —        39,486       (39,486     (16,603     (16,603
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Earnings (loss) before income taxes

     252,973       20,454       (160,879     37,403       (126,052     23,899  

Income tax recovery

               30,960  
            

 

 

 

Net loss

             $ (7,061
            

 

 

 

 

(i)

Consistent with the presentation of financial information for internal management purposes, Cameco’s share of Westinghouse’s financial results has been presented as a separate segment. In accordance with IFRS, this investment is accounted for by the equity method of accounting in these consolidated financial statements and the associated revenue and expenses are eliminated in the “Adjustments” column.

 

24


For the three months ended March 31, 2023

 

     Uranium     Fuel services     Other     Total  

Revenue

   $ 594,576     $ 92,399     $ —      $ 686,975  

Expenses

        

Cost of products and services sold

     390,018       54,129       (725     443,422  

Depreciation and amortization

     67,877       7,550       946       76,373  
  

 

 

   

 

 

   

 

 

   

 

 

 

Cost of sales

     457,895       61,679       221       519,795  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit (loss)

     136,681       30,720       (221     167,180  

Administration

     —        —        64,011       64,011  

Exploration

     6,279       —        —        6,279  

Research and development

     —        —        4,232       4,232  

Other operating income

     (1,756     (291     —        (2,047

Finance costs

     —        —        23,597       23,597  

Gain on derivatives

     —        —        (2,270     (2,270

Finance income

     —        —        (27,540     (27,540

Share of earnings from equity-accounted investee

     (56,536     —        —        (56,536

Other expense

     —        —        2,586       2,586  
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings (loss) before income taxes

     188,694       31,011       (64,837     154,868  

Income tax expense

           35,904  
        

 

 

 

Net earnings

         $ 118,964  
        

 

 

 

21. Related parties

Transactions with key management personnel

Key management personnel are those persons that the authority and responsibility for planning, directing and controlling the activities of the Company, directly or indirectly. Key management personnel of the Company include executive officers, vice-presidents, other senior managers and members of the board of directors.

Certain key management personnel, or their related parties, hold positions in other entities that result in them having control or significant influence over the financial or operating policies of those entities. As noted below, some of these entities transacted with the Company in the reporting period. The terms and conditions of the transactions were on an arm’s length basis.

Cameco purchases a significant amount of goods and services for its Saskatchewan mining operations from northern Saskatchewan suppliers to support economic development in the region. The president of several of these suppliers became a member of the board of directors of Cameco in September 2023. During the first quarter of 2024, Cameco paid these suppliers $25,988,000 for construction and contracting services. The transactions were conducted in the normal course of business and were accounted for at the exchange amount. Accounts payable includes a balance of $99,000 at the reporting date.

Other related party transactions

Westinghouse

Cameco has entered into various agreements with Westinghouse and its subsidiaries. For the quarter ended March 31, 2024, Cameco has recognized sales revenue of $45,182,000 ($33,349,000 (US)) related to fuel supply agreements and incurred costs of $24,000 ($18,000 (US)) related to fuel storage and handling fees. Contract terms are at market rates and on normal trade terms.

 

25


JV Inkai

Cameco purchases uranium concentrate from JV Inkai. For the quarter ended March 31, 2024, Cameco had purchases of $145,784,000 ($108,672,000 (US)) (2023 - $0). Purchases from JV Inkai are at market rates with extended payment terms.

 

26